Erika Kovacs-Bogdan

Erika Kovacs-Bogdan, Ph.D.

Erika Kovacs-Bogdan

Erika Kovacs-Bogdan is a senior alliance manager at the Broad Institute, responsible for managing industry-sponsored drug discovery collaborations in the cardiometabolic and diabetes fields. She is responsible for managing the relationship with partner organizations, overseeing and supporting the development of portfolios, and working across multidisciplinary teams of scientists and various administrative functions (finance, legal, business, and development) to ensure the success of collaborations.

Previously, Kovacs-Bogdan was a research scientist and project team lead under the direction of Patrick Ellinor in the Cardiovascular Disease Initiative (CVDi) in the Broad-Bayer cardiovascular collaboration, focusing on the characterization and validation of novel therapeutic candidates for treatment of heart disease.

Prior to joining the Broad Institute in 2015, Kovacs-Bogdan undertook postdoctoral training in the lab of Vamsi Mootha at Massachusetts General Hospital, and reconstituted the mitochondrial calcium uniporter in yeast to study its function. She joined the Broad Institute as a research scientist in the Thomas lab of the Broad Institute’s Cancer Program, and later joined the CVDi in May 2017.

Kovacs-Bogdan obtained a Ph.D. in biochemistry at Ludwig Maximilians University, Munich, Germany, in the lab of Prof. Juergen Soll. She also holds a M.S. in biology and chemistry from Eotvos Lorand University, Budapest, Hungary.

Contact Erika Kovacs-Bogdan via email at

September 2023